APO Research
Talk to an analyst

APO RESEARCH · REPORT

Injectable Ketamine

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Injectable Ketamine Market Outlook and Growth Opportunities 2026

26 December 2025190 pages

Choose your research edition.

Industry ResearchInjectable Ketamine Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Injectable Ketamine Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Injectable Ketamine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Injectable Ketamine Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Injectable Ketamine Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Injectable Ketamine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Injectable Ketamine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Injectable Ketamine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Injectable Ketamine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Injectable Ketamine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Injectable Ketamine market include Anhui Wanhe Pharmaceutical, Pfizer, Hengrui, Troikaa Parenterals, Taj Pharmaceuticals, Supriya Lifesciences, Sun Pharmaceuticals, Seqens and Samarth Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Injectable Ketamine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Injectable Ketamine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Injectable Ketamine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Injectable Ketamine market size, projected growth trends, production technologies, key applications, and end-use industries.

Injectable Ketamine Segment by Company

Anhui Wanhe Pharmaceutical

Pfizer

Hengrui

Troikaa Parenterals

Taj Pharmaceuticals

Supriya Lifesciences

Sun Pharmaceuticals

Seqens

Samarth Pharma

Neon Laboratories

Ketalar

Hameln Pharma ltd

Greenco Biologicals

BNM Organics

Injectable Ketamine Segment by Type

Standard Ketamine

Low-Dose Ketamine

High-Dose Ketamine

Injectable Ketamine Segment by Application

Mental Health Treatment

Pain Management

Anesthetic Use

Injectable Ketamine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Injectable Ketamine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Injectable Ketamine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Injectable Ketamine significant trends, drivers, influence factors in global and regions.

6. To analyze Injectable Ketamine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Injectable Ketamine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Injectable Ketamine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Injectable Ketamine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Injectable Ketamine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Injectable Ketamine industry.

Chapter 3: Detailed analysis of Injectable Ketamine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Injectable Ketamine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Injectable Ketamine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Injectable Ketamine Industry Trends Table 2. Injectable Ketamine Industry Drivers Table 3. Injectable Ketamine Industry Opportunities and Challenges Table 4. Injectable Ketamine Industry Restraints Table 5. Global Injectable Ketamine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Injectable Ketamine Revenue Share by Company (2021-2026) Table 7. Global Injectable Ketamine Sales Volume by Company (Kg) & (2021-2026) Table 8. Global Injectable Ketamine Sales Volume Share by Company (2021-2026) Table 9. Global Injectable Ketamine Average Price (US$/g) of Company (2021-2026) Table 10. Global Injectable Ketamine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Injectable Ketamine Key Company Manufacturing Base & Headquarters Table 12. Global Injectable Ketamine Company, Product Type & Application Table 13. Global Injectable Ketamine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Injectable Ketamine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Standard Ketamine Table 18. Significant Companies of Low-Dose Ketamine Table 19. Significant Companies of High-Dose Ketamine Table 20. Global Injectable Ketamine Sales Volume by Type 2021 VS 2025 VS 2032 (Kg) Table 21. Global Injectable Ketamine Sales Volume by Type (2021-2026) & (Kg) Table 22. Global Injectable Ketamine Sales Volume by Type (2027-2032) & (Kg) Table 23. Global Injectable Ketamine Sales Volume Share by Type (2021-2026) Table 24. Global Injectable Ketamine Sales Volume Share by Type (2027-2032) Table 25. Global Injectable Ketamine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Injectable Ketamine Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Injectable Ketamine Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Injectable Ketamine Sales Value Share by Type (2021-2026) Table 29. Global Injectable Ketamine Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Mental Health Treatment Table 31. Significant Companies of Pain Management Table 32. Significant Companies of Anesthetic Use Table 33. Global Injectable Ketamine Sales Volume by Application 2021 VS 2025 VS 2032 (Kg) Table 34. Global Injectable Ketamine Sales Volume by Application (2021-2026) & (Kg) Table 35. Global Injectable Ketamine Sales Volume by Application (2027-2032) & (Kg) Table 36. Global Injectable Ketamine Sales Volume Share by Application (2021-2026) Table 37. Global Injectable Ketamine Sales Volume Share by Application (2027-2032) Table 38. Global Injectable Ketamine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Injectable Ketamine Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Injectable Ketamine Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Injectable Ketamine Sales Value Share by Application (2021-2026) Table 42. Global Injectable Ketamine Sales Value Share by Application (2027-2032) Table 43. Global Injectable Ketamine Sales by Region: 2021 VS 2025 VS 2032 (Kg) Table 44. Global Injectable Ketamine Sales by Region (2021-2026) & (Kg) Table 45. Global Injectable Ketamine Sales Market Share by Region (2021-2026) Table 46. Global Injectable Ketamine Sales by Region (2027-2032) & (Kg) Table 47. Global Injectable Ketamine Sales Market Share by Region (2027-2032) Table 48. Global Injectable Ketamine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Injectable Ketamine Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Injectable Ketamine Sales Value Share by Region (2021-2026) Table 51. Global Injectable Ketamine Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Injectable Ketamine Sales Value Share by Region (2027-2032) Table 53. Global Injectable Ketamine Market Average Price (US$/g) by Region (2021-2026) Table 54. Global Injectable Ketamine Market Average Price (US$/g) by Region (2027-2032) Table 55. Global Injectable Ketamine Sales by Country: 2021 VS 2025 VS 2032 (Kg) Table 56. Global Injectable Ketamine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Injectable Ketamine Sales by Country (2021-2026) & (Kg) Table 58. Global Injectable Ketamine Sales Market Share by Country (2021-2026) Table 59. Global Injectable Ketamine Sales by Country (2027-2032) & (Kg) Table 60. Global Injectable Ketamine Sales Market Share by Country (2027-2032) Table 61. Global Injectable Ketamine Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Injectable Ketamine Sales Value Market Share by Country (2021-2026) Table 63. Global Injectable Ketamine Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Injectable Ketamine Sales Value Market Share by Country (2027-2032) Table 65. Anhui Wanhe Pharmaceutical Company Information Table 66. Anhui Wanhe Pharmaceutical Business Overview Table 67. Anhui Wanhe Pharmaceutical Injectable Ketamine Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 68. Anhui Wanhe Pharmaceutical Injectable Ketamine Product Portfolio Table 69. Anhui Wanhe Pharmaceutical Recent Development Table 70. Pfizer Company Information Table 71. Pfizer Business Overview Table 72. Pfizer Injectable Ketamine Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 73. Pfizer Injectable Ketamine Product Portfolio Table 74. Pfizer Recent Development Table 75. Hengrui Company Information Table 76. Hengrui Business Overview Table 77. Hengrui Injectable Ketamine Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 78. Hengrui Injectable Ketamine Product Portfolio Table 79. Hengrui Recent Development Table 80. Troikaa Parenterals Company Information Table 81. Troikaa Parenterals Business Overview Table 82. Troikaa Parenterals Injectable Ketamine Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 83. Troikaa Parenterals Injectable Ketamine Product Portfolio Table 84. Troikaa Parenterals Recent Development Table 85. Taj Pharmaceuticals Company Information Table 86. Taj Pharmaceuticals Business Overview Table 87. Taj Pharmaceuticals Injectable Ketamine Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 88. Taj Pharmaceuticals Injectable Ketamine Product Portfolio Table 89. Taj Pharmaceuticals Recent Development Table 90. Supriya Lifesciences Company Information Table 91. Supriya Lifesciences Business Overview Table 92. Supriya Lifesciences Injectable Ketamine Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 93. Supriya Lifesciences Injectable Ketamine Product Portfolio Table 94. Supriya Lifesciences Recent Development Table 95. Sun Pharmaceuticals Company Information Table 96. Sun Pharmaceuticals Business Overview Table 97. Sun Pharmaceuticals Injectable Ketamine Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 98. Sun Pharmaceuticals Injectable Ketamine Product Portfolio Table 99. Sun Pharmaceuticals Recent Development Table 100. Seqens Company Information Table 101. Seqens Business Overview Table 102. Seqens Injectable Ketamine Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 103. Seqens Injectable Ketamine Product Portfolio Table 104. Seqens Recent Development Table 105. Samarth Pharma Company Information Table 106. Samarth Pharma Business Overview Table 107. Samarth Pharma Injectable Ketamine Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 108. Samarth Pharma Injectable Ketamine Product Portfolio Table 109. Samarth Pharma Recent Development Table 110. Neon Laboratories Company Information Table 111. Neon Laboratories Business Overview Table 112. Neon Laboratories Injectable Ketamine Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 113. Neon Laboratories Injectable Ketamine Product Portfolio Table 114. Neon Laboratories Recent Development Table 115. Ketalar Company Information Table 116. Ketalar Business Overview Table 117. Ketalar Injectable Ketamine Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 118. Ketalar Injectable Ketamine Product Portfolio Table 119. Ketalar Recent Development Table 120. Hameln Pharma ltd Company Information Table 121. Hameln Pharma ltd Business Overview Table 122. Hameln Pharma ltd Injectable Ketamine Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 123. Hameln Pharma ltd Injectable Ketamine Product Portfolio Table 124. Hameln Pharma ltd Recent Development Table 125. Greenco Biologicals Company Information Table 126. Greenco Biologicals Business Overview Table 127. Greenco Biologicals Injectable Ketamine Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 128. Greenco Biologicals Injectable Ketamine Product Portfolio Table 129. Greenco Biologicals Recent Development Table 130. BNM Organics Company Information Table 131. BNM Organics Business Overview Table 132. BNM Organics Injectable Ketamine Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 133. BNM Organics Injectable Ketamine Product Portfolio Table 134. BNM Organics Recent Development Table 135. Key Raw Materials Table 136. Raw Materials Key Suppliers Table 137. Injectable Ketamine Distributors List Table 138. Injectable Ketamine Customers List Table 139. Research Programs/Design for This Report Table 140. Authors List of This Report Table 141. Secondary Sources Table 142. Primary Sources List of Figures Figure 1. Injectable Ketamine Product Image Figure 2. Global Injectable Ketamine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Injectable Ketamine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Injectable Ketamine Sales (2021-2032) & (Kg) Figure 5. Global Injectable Ketamine Sales Average Price (US$/g) & (2021-2032) Figure 6. Global Injectable Ketamine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Standard Ketamine Image Figure 10. Low-Dose Ketamine Image Figure 11. High-Dose Ketamine Image Figure 12. Global Injectable Ketamine Sales Volume by Type (2021 VS 2025 VS 2032) & (Kg) Figure 13. Global Injectable Ketamine Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Injectable Ketamine Sales Volume Share by Type (2021-2032) Figure 15. Global Injectable Ketamine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Injectable Ketamine Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Injectable Ketamine Sales Value Share by Type (2021-2032) Figure 18. Mental Health Treatment Image Figure 19. Pain Management Image Figure 20. Anesthetic Use Image Figure 21. Global Injectable Ketamine Sales Volume by Application (2021 VS 2025 VS 2032) & (Kg) Figure 22. Global Injectable Ketamine Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Injectable Ketamine Sales Volume Share by Application (2021-2032) Figure 24. Global Injectable Ketamine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Injectable Ketamine Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Injectable Ketamine Sales Value Share by Application (2021-2032) Figure 27. Global Injectable Ketamine Sales by Region: 2021 VS 2025 VS 2032 (Kg) Figure 28. Global Injectable Ketamine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Injectable Ketamine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Injectable Ketamine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Injectable Ketamine Sales Value (2021-2032) & (US$ Million) Figure 32. North America Injectable Ketamine Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Injectable Ketamine Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Injectable Ketamine Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Injectable Ketamine Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Injectable Ketamine Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Injectable Ketamine Sales Value (2021-2032) & (US$ Million) Figure 38. South America Injectable Ketamine Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Injectable Ketamine Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Injectable Ketamine Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Injectable Ketamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Injectable Ketamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Injectable Ketamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Injectable Ketamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Injectable Ketamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Injectable Ketamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Injectable Ketamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Injectable Ketamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Injectable Ketamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Injectable Ketamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Injectable Ketamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Injectable Ketamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Injectable Ketamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Injectable Ketamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Injectable Ketamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Injectable Ketamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Injectable Ketamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Injectable Ketamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Injectable Ketamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Injectable Ketamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Injectable Ketamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Injectable Ketamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Injectable Ketamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Injectable Ketamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Injectable Ketamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Injectable Ketamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Injectable Ketamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Injectable Ketamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Injectable Ketamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Injectable Ketamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Injectable Ketamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Injectable Ketamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Injectable Ketamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Injectable Ketamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Injectable Ketamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Injectable Ketamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Injectable Ketamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Injectable Ketamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Injectable Ketamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Injectable Ketamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Injectable Ketamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Injectable Ketamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Injectable Ketamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Injectable Ketamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Injectable Ketamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Injectable Ketamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Injectable Ketamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Injectable Ketamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Injectable Ketamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Injectable Ketamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Injectable Ketamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Injectable Ketamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Injectable Ketamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Injectable Ketamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Injectable Ketamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Injectable Ketamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Injectable Ketamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Injectable Ketamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Injectable Ketamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Injectable Ketamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Injectable Ketamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Injectable Ketamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Injectable Ketamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Injectable Ketamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Injectable Ketamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Injectable Ketamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Injectable Ketamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Injectable Ketamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Injectable Ketamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Injectable Ketamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Injectable Ketamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Injectable Ketamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Injectable Ketamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Injectable Ketamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Injectable Ketamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Injectable Ketamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Injectable Ketamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Injectable Ketamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Injectable Ketamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Injectable Ketamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Injectable Ketamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Injectable Ketamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Injectable Ketamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Injectable Ketamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Injectable Ketamine Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Injectable Ketamine Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Standard Ketamine
  • Low-Dose Ketamine
  • High-Dose Ketamine
Applications
  • Mental Health Treatment
  • Pain Management
  • Anesthetic Use
Companies covered
  • Anhui Wanhe Pharmaceutical
  • Pfizer
  • Hengrui
  • Troikaa Parenterals
  • Taj Pharmaceuticals
  • Supriya Lifesciences
  • Sun Pharmaceuticals
  • Seqens
  • Samarth Pharma
  • Neon Laboratories
  • Ketalar
  • Hameln Pharma ltd
  • Greenco Biologicals
  • BNM Organics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Injectable Ketamine Sales Value (2021-2032)
  4. 1.2.2 Global Injectable Ketamine Sales Volume (2021-2032)
  5. 1.2.3 Global Injectable Ketamine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Injectable Ketamine Market Dynamics
  1. 2.1 Injectable Ketamine Industry Trends
  2. 2.2 Injectable Ketamine Industry Drivers
  3. 2.3 Injectable Ketamine Industry Opportunities and Challenges
  4. 2.4 Injectable Ketamine Industry Restraints
3 Injectable Ketamine Market by Company
  1. 3.1 Global Injectable Ketamine Company Revenue Ranking in 2025
  2. 3.2 Global Injectable Ketamine Revenue by Company (2021-2026)
  3. 3.3 Global Injectable Ketamine Sales Volume by Company (2021-2026)
  4. 3.4 Global Injectable Ketamine Average Price by Company (2021-2026)
  5. 3.5 Global Injectable Ketamine Company Ranking (2024-2026)
  6. 3.6 Global Injectable Ketamine Company Manufacturing Base and Headquarters
  7. 3.7 Global Injectable Ketamine Company Product Type and Application
  8. 3.8 Global Injectable Ketamine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Injectable Ketamine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Injectable Ketamine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Injectable Ketamine Market by Type
  1. 4.1 Injectable Ketamine Type Introduction
  2. 4.1.1 Standard Ketamine
  3. 4.1.2 Low-Dose Ketamine
  4. 4.1.3 High-Dose Ketamine
  5. 4.2 Global Injectable Ketamine Sales Volume by Type
  6. 4.2.1 Global Injectable Ketamine Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Injectable Ketamine Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Injectable Ketamine Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Injectable Ketamine Sales Value by Type
  10. 4.3.1 Global Injectable Ketamine Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Injectable Ketamine Sales Value by Type (2021-2032)
  12. 4.3.3 Global Injectable Ketamine Sales Value Share by Type (2021-2032)
5 Injectable Ketamine Market by Application
  1. 5.1 Injectable Ketamine Application Introduction
  2. 5.1.1 Mental Health Treatment
  3. 5.1.2 Pain Management
  4. 5.1.3 Anesthetic Use
  5. 5.2 Global Injectable Ketamine Sales Volume by Application
  6. 5.2.1 Global Injectable Ketamine Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Injectable Ketamine Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Injectable Ketamine Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Injectable Ketamine Sales Value by Application
  10. 5.3.1 Global Injectable Ketamine Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Injectable Ketamine Sales Value by Application (2021-2032)
  12. 5.3.3 Global Injectable Ketamine Sales Value Share by Application (2021-2032)
6 Injectable Ketamine Regional Sales and Value Analysis
  1. 6.1 Global Injectable Ketamine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Injectable Ketamine Sales by Region (2021-2032)
  3. 6.2.1 Global Injectable Ketamine Sales by Region: 2021-2026
  4. 6.2.2 Global Injectable Ketamine Sales by Region (2027-2032)
  5. 6.3 Global Injectable Ketamine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Injectable Ketamine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Injectable Ketamine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Injectable Ketamine Sales Value by Region (2027-2032)
  9. 6.5 Global Injectable Ketamine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Injectable Ketamine Sales Value (2021-2032)
  12. 6.6.2 North America Injectable Ketamine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Injectable Ketamine Sales Value (2021-2032)
  15. 6.7.2 Europe Injectable Ketamine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Injectable Ketamine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Injectable Ketamine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Injectable Ketamine Sales Value (2021-2032)
  21. 6.9.2 South America Injectable Ketamine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Injectable Ketamine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Injectable Ketamine Sales Value Share by Country, 2025 VS 2032
7 Injectable Ketamine Country-level Sales and Value Analysis
  1. 7.1 Global Injectable Ketamine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Injectable Ketamine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Injectable Ketamine Sales by Country (2021-2032)
  4. 7.3.1 Global Injectable Ketamine Sales by Country (2021-2026)
  5. 7.3.2 Global Injectable Ketamine Sales by Country (2027-2032)
  6. 7.4 Global Injectable Ketamine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Injectable Ketamine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Injectable Ketamine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Injectable Ketamine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Injectable Ketamine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Injectable Ketamine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Injectable Ketamine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Injectable Ketamine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Injectable Ketamine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Injectable Ketamine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Injectable Ketamine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Injectable Ketamine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Injectable Ketamine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Injectable Ketamine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Injectable Ketamine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Injectable Ketamine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Injectable Ketamine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Injectable Ketamine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Injectable Ketamine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Injectable Ketamine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Injectable Ketamine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Injectable Ketamine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Injectable Ketamine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Injectable Ketamine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Injectable Ketamine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Injectable Ketamine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Injectable Ketamine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Injectable Ketamine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Injectable Ketamine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Injectable Ketamine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Injectable Ketamine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Injectable Ketamine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Injectable Ketamine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Injectable Ketamine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Injectable Ketamine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Injectable Ketamine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Injectable Ketamine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Injectable Ketamine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Injectable Ketamine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Injectable Ketamine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Injectable Ketamine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Injectable Ketamine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Injectable Ketamine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Injectable Ketamine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Injectable Ketamine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Injectable Ketamine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Injectable Ketamine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Injectable Ketamine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Injectable Ketamine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Injectable Ketamine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Injectable Ketamine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Injectable Ketamine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Injectable Ketamine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Injectable Ketamine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Injectable Ketamine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Injectable Ketamine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Injectable Ketamine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Injectable Ketamine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Injectable Ketamine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Injectable Ketamine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Injectable Ketamine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Injectable Ketamine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Injectable Ketamine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Injectable Ketamine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Injectable Ketamine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Injectable Ketamine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Injectable Ketamine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Injectable Ketamine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Injectable Ketamine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Injectable Ketamine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Injectable Ketamine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Injectable Ketamine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Injectable Ketamine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Injectable Ketamine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Injectable Ketamine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Injectable Ketamine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Injectable Ketamine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Injectable Ketamine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Injectable Ketamine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Injectable Ketamine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Injectable Ketamine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Injectable Ketamine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Injectable Ketamine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Injectable Ketamine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Injectable Ketamine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Injectable Ketamine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Injectable Ketamine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Anhui Wanhe Pharmaceutical
  2. 8.1.1 Anhui Wanhe Pharmaceutical Company Information
  3. 8.1.2 Anhui Wanhe Pharmaceutical Business Overview
  4. 8.1.3 Anhui Wanhe Pharmaceutical Injectable Ketamine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Anhui Wanhe Pharmaceutical Injectable Ketamine Product Portfolio
  6. 8.1.5 Anhui Wanhe Pharmaceutical Recent Developments
  7. 8.2 Pfizer
  8. 8.2.1 Pfizer Company Information
  9. 8.2.2 Pfizer Business Overview
  10. 8.2.3 Pfizer Injectable Ketamine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Pfizer Injectable Ketamine Product Portfolio
  12. 8.2.5 Pfizer Recent Developments
  13. 8.3 Hengrui
  14. 8.3.1 Hengrui Company Information
  15. 8.3.2 Hengrui Business Overview
  16. 8.3.3 Hengrui Injectable Ketamine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Hengrui Injectable Ketamine Product Portfolio
  18. 8.3.5 Hengrui Recent Developments
  19. 8.4 Troikaa Parenterals
  20. 8.4.1 Troikaa Parenterals Company Information
  21. 8.4.2 Troikaa Parenterals Business Overview
  22. 8.4.3 Troikaa Parenterals Injectable Ketamine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Troikaa Parenterals Injectable Ketamine Product Portfolio
  24. 8.4.5 Troikaa Parenterals Recent Developments
  25. 8.5 Taj Pharmaceuticals
  26. 8.5.1 Taj Pharmaceuticals Company Information
  27. 8.5.2 Taj Pharmaceuticals Business Overview
  28. 8.5.3 Taj Pharmaceuticals Injectable Ketamine Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Taj Pharmaceuticals Injectable Ketamine Product Portfolio
  30. 8.5.5 Taj Pharmaceuticals Recent Developments
  31. 8.6 Supriya Lifesciences
  32. 8.6.1 Supriya Lifesciences Company Information
  33. 8.6.2 Supriya Lifesciences Business Overview
  34. 8.6.3 Supriya Lifesciences Injectable Ketamine Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Supriya Lifesciences Injectable Ketamine Product Portfolio
  36. 8.6.5 Supriya Lifesciences Recent Developments
  37. 8.7 Sun Pharmaceuticals
  38. 8.7.1 Sun Pharmaceuticals Company Information
  39. 8.7.2 Sun Pharmaceuticals Business Overview
  40. 8.7.3 Sun Pharmaceuticals Injectable Ketamine Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Sun Pharmaceuticals Injectable Ketamine Product Portfolio
  42. 8.7.5 Sun Pharmaceuticals Recent Developments
  43. 8.8 Seqens
  44. 8.8.1 Seqens Company Information
  45. 8.8.2 Seqens Business Overview
  46. 8.8.3 Seqens Injectable Ketamine Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Seqens Injectable Ketamine Product Portfolio
  48. 8.8.5 Seqens Recent Developments
  49. 8.9 Samarth Pharma
  50. 8.9.1 Samarth Pharma Company Information
  51. 8.9.2 Samarth Pharma Business Overview
  52. 8.9.3 Samarth Pharma Injectable Ketamine Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Samarth Pharma Injectable Ketamine Product Portfolio
  54. 8.9.5 Samarth Pharma Recent Developments
  55. 8.10 Neon Laboratories
  56. 8.10.1 Neon Laboratories Company Information
  57. 8.10.2 Neon Laboratories Business Overview
  58. 8.10.3 Neon Laboratories Injectable Ketamine Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Neon Laboratories Injectable Ketamine Product Portfolio
  60. 8.10.5 Neon Laboratories Recent Developments
  61. 8.11 Ketalar
  62. 8.11.1 Ketalar Company Information
  63. 8.11.2 Ketalar Business Overview
  64. 8.11.3 Ketalar Injectable Ketamine Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Ketalar Injectable Ketamine Product Portfolio
  66. 8.11.5 Ketalar Recent Developments
  67. 8.12 Hameln Pharma ltd
  68. 8.12.1 Hameln Pharma ltd Company Information
  69. 8.12.2 Hameln Pharma ltd Business Overview
  70. 8.12.3 Hameln Pharma ltd Injectable Ketamine Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Hameln Pharma ltd Injectable Ketamine Product Portfolio
  72. 8.12.5 Hameln Pharma ltd Recent Developments
  73. 8.13 Greenco Biologicals
  74. 8.13.1 Greenco Biologicals Company Information
  75. 8.13.2 Greenco Biologicals Business Overview
  76. 8.13.3 Greenco Biologicals Injectable Ketamine Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Greenco Biologicals Injectable Ketamine Product Portfolio
  78. 8.13.5 Greenco Biologicals Recent Developments
  79. 8.14 BNM Organics
  80. 8.14.1 BNM Organics Company Information
  81. 8.14.2 BNM Organics Business Overview
  82. 8.14.3 BNM Organics Injectable Ketamine Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 BNM Organics Injectable Ketamine Product Portfolio
  84. 8.14.5 BNM Organics Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Injectable Ketamine Value Chain Analysis
  2. 9.1.1 Injectable Ketamine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Injectable Ketamine Sales Mode & Process
  6. 9.2 Injectable Ketamine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Injectable Ketamine Distributors
  9. 9.2.3 Injectable Ketamine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst